Document is current
Any future updates will be listed below
-
Authors
Shin, Incheol
Kang, Keumseok
Kim, Juseong
Sel, Sanghun
Choi, Jeonghoon
Lee, Jae-Wook
Kang, Ho Young
Song, Giltae
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (2021R1A2C2010775)
National Research Foundation of Korea (2021R1A2C2010775)
National Research Foundation of Korea (2021R1A2C2010775)
National Research Foundation of Korea (2021R1A2C2010775)
National Research Foundation of Korea (2021R1A2C2010775)
National Research Foundation of Korea (2021R1A2C2010775)
Institute of Information & Communications Technology Planning & Evaluation (IITP-2023-00254177)
Institute of Information & Communications Technology Planning & Evaluation (IITP-2023-00254177)
Institute of Information & Communications Technology Planning & Evaluation (IITP-2023-00254177)
Institute of Information & Communications Technology Planning & Evaluation (IITP-2023-00254177)
Institute of Information & Communications Technology Planning & Evaluation (IITP-2023-00254177)
- License Information
-
More Information
Article History
Received: 24 August 2023
Accepted: 21 November 2023
First Online: 27 November 2023
Declarations
:
: Not applicable.
: Not applicable.
: J.L. and H.Y.K. are full-time employees of Nuclixbio, a biopharmaceutical company that develops cell-penetrating biologics targeting intracellular oncoproteins with proprietary nanocarriers. This commercial affiliation does not alter our adherence to the <i>BMC Bioinformatics</i> policies on sharing data and materials. Other authors declared no competing interests.
